Long-read genome sequencing is emerging as a superior diagnostic tool for rare genetic disorders, outperforming standard short-read methods by identifying complex structural variants and DNA modifications in a single test. According to a study published in the New England Journal of Medicine by researchers at Radboud University Medical Center and Maastricht University Medical Center+, the technology provides a 3% higher diagnostic yield while replacing 15 separate traditional clinical tests.
How long-read sequencing improves accuracy
Standard diagnostic tests typically analyze DNA in small, fragmented segments of roughly 300 building blocks. In contrast, long-read genome sequencing reads segments of up to 20,000 building blocks. This extended scale simplifies the assembly of complex genetic sequences, allowing clinicians to map areas of the genome that are difficult to interpret using conventional methods, according to Lisenka Vissers, professor of translational genomics.
Beyond mapping, the technology captures epigenetic modifications—chemical tags on the outside of DNA that dictate gene activity. “With current diagnostics, this requires additional specialized tests, but with long reads we capture these modifications as a bonus—two in one,” says Christian Gilissen, professor of genome bioinformatics.
Clinical impact and diagnostic efficiency
The transition to long-read sequencing could significantly streamline clinical workflows. By replacing 15 disparate tests with a single, more accurate diagnostic, medical centers can reduce the time-to-diagnosis for patients with rare conditions. Researchers tested this approach on 1,000 patients, finding that the increased detail directly correlated to more frequent clinical findings.
The practical application of this technology was demonstrated during the Undiagnosed Hackathon in Nijmegen. Specialists from Dutch university medical centers used the platform to analyze 33 families, resulting in five new diagnoses. Alexander Hoischen, professor of genomic technologies, notes that as the collective knowledge base grows, the ability to link complex, previously unidentified abnormalities to specific conditions will only improve.
Comparing standard vs. long-read diagnostics
The shift represents a move from fragmented analysis to a holistic view of the genome. While short-read sequencing remains common for basic screening, its inability to resolve complex structural variations often leads to “diagnostic odysseys” for patients.
| Feature | Standard Diagnostics | Long-Read Sequencing |
|---|---|---|
| Segment size | ~300 building blocks | Up to 20,000 building blocks |
| Epigenetic data | Requires separate tests | Captured as a “bonus” |
| Diagnostic yield | Baseline | 3% increase observed |
Frequently Asked Questions
What makes long-read sequencing different from standard tests?
It reads significantly larger pieces of DNA, which allows for easier assembly of the genome and the detection of complex structural abnormalities that smaller fragments often miss.
Can this test identify gene regulation issues?
Yes. Because it reads longer segments, it can detect modifications on the outside of the DNA that switch genes on or off, acting as both a sequencing tool and an epigenetic analyzer.
Is this technology currently in use?
Yes. Researchers at Radboud University Medical Center and Maastricht University Medical Center+ have validated its use in clinical settings and advocate for its adoption as a primary diagnostic choice.
The recent Undiagnosed Hackathon in Nijmegen successfully turned 33 complex, unresolved cases into five clear diagnoses using this advanced sequencing method.
Are you a clinician interested in the latest advancements in molecular diagnostics? Subscribe to our clinical newsletter for regular updates on genomic technology and laboratory innovations.